The total number of Board members of the Investee.

No definition available.

Name:	inva_NumberOfBoardMembersOfInvestee
Namespace Prefix:	inva_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

The number of the Company's Board members currently serving on the Investee's Board.

+ References

No definition available.

+ Details

Name:	inva_NumberOfCompanysBoardMembersCurrentlyServingOnBoardOfInvestee
Namespace Prefix:	inva_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

The number of warrants issued or sold by the subsidiary or equity method investee per stock transaction.

+ References

No definition available.

+ Details

Name:	inva_SaleOfWarrantsNumberOfWarrantsIssuedInTransaction
Namespace Prefix:	inva_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount the Company agreed to pay for common stock and warrants upon satisfaction of certain closing conditions under the terms of the securities purchase agreement.

+ References

No definition available.

+ Details

Name:	inva_SecuritiesPurchaseAgreementAmount
Namespace Prefix:	inva_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The number of tranches in which the Company agreed to purchase common stock and warrants upon satisfaction of certain closing conditions under the terms of the securities purchase agreement.

+ References

No definition available.

+ Details

Name:	inva_SecuritiesPurchaseAgreementNumberOfTranches
Namespace Prefix:	inva_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

The total number of shares to be purchased under the terms of a securities purchase agreement.

+ References

No definition available.

+ Details

Name:	inva_SecuritiesPurchaseAgreementTotalNumberOfSharesToBePurchasedUnderAgreement
Namespace Prefix:	inva_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

The total number of warrants to be purchased under the terms of a securities purchase agreement.

+ References

No definition available.

+ Details

Name:	inva_SecuritiesPurchaseAgreementTotalNumberOfWarrantsToBePurchasedUnderAgreement
Namespace Prefix:	inva_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Represents the percentage of maximum voting rights under voting agreement.

+ References

No definition available.

+ Details

Name:	inva_VotingAgreementMaximumVotingRightsPercent
Namespace Prefix:	inva_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Exercise price per share or per unit of warrants or rights outstanding.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644

+ Details

Name:	us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (a)(1)
-URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

+ Details

Name:	us-gaap_EquityMethodInvestmentOwnershipPercentage
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(2))
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 45
-Paragraph 1A
-URI https://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740

+ Details

Name:	us-gaap_EquitySecuritiesFvNi
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Amount of unrealized gain on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 321
-SubTopic 10
-Section 50
-Paragraph 4
-URI https://asc.fasb.org/extlink&oid=126980263&loc=SL75117546-209714

+ Details

Name:	us-gaap_EquitySecuritiesFvNiUnrealizedGain
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of unrealized loss on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).

+ References

+ Details

Name:	us-gaap_EquitySecuritiesFvNiUnrealizedLoss
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.

+ References

No definition available.

+ Details

Name:	us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 5A
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685

+ Details

Name:	us-gaap_VariableInterestEntityOwnershipPercentage
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (bbb)(2)
-URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258

+ Details

Name:	us-gaap_WarrantsAndRightsOutstandingTerm
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	instant

- Details

Name:	srt_ConsolidatedEntitiesAxis=inva_ArmataPharmaceuticalsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_TitleOfIndividualAxis=inva_TwoDirectorsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FinancialInstrumentAxis=inva_CommonStockAndWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FinancialInstrumentAxis=inva_WarrantsPurchasedIn2020Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FinancialInstrumentAxis=inva_WarrantsPurchasedIn2021Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FinancialInstrumentAxis=inva_WarrantsPurchasedIn2022Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_TitleOfIndividualAxis=inva_OneDirectorMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=inva_InnovivaStrategicOpportunitiesLimitedLiabilityCorporationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Financial Instruments and Fair Value Measurements - Equity Investment in Armata (Details) - Armata $ / shares in Units, $ in Millions		3 Months Ended					6 Months Ended
	Feb. 09, 2022 USD ($) $ / shares shares	Jun. 30, 2022 USD ($) Director $ / shares	Dec. 31, 2021 USD ($) shares	Jun. 30, 2021 USD ($)	Mar. 31, 2021 USD ($) $ / shares shares	Mar. 31, 2020 USD ($) $ / shares shares	Jun. 30, 2022 USD ($) Tranche Director $ / shares	Jun. 30, 2021 USD ($)
Equity investment
Number of tranches \| Tranche							2
Equity investment ownership percentage		69.40%	59.30%				69.40%
Percentage of maximum voting rights	49.50%						49.50%
Number of Investee's Board members currently representing the Company \| Director		3					3
Number of the Investee's Board members \| Director		8					8
Unrealized gain from fair value changes in equity investments								$ 36.9
Unrealized loss from fair value changes in equity investments		$ 42.8		$ 24.3			$ 47.0
Two Directors
Equity investment
Armata outstanding shares percentage	12.50%
Common stock and warrants
Equity investment
Amount of securities purchase agreement						$ 25.0
Equity and long-term investments at fair value		$ 144.7	$ 146.7				$ 144.7
Warrants purchased in 2020
Equity investment
Exercise price of warrants \| $ / shares						$ 2.87
Term of warrants		5 years					5 years
Warrants purchased in 2021
Equity investment
Exercise price of warrants \| $ / shares					$ 3.25
Term of warrants		5 years					5 years
Warrants purchased in 2022 Member
Equity investment
Exercise price of warrants \| $ / shares		$ 5.00					$ 5.00
Term of warrants		5 years					5 years
Warrants
Equity investment
Number of warrants purchased under the securities purchase agreement \| shares						8,710,800
Equity and long-term investments at fair value		$ 47.1	$ 58.6				$ 47.1
Common stock
Equity investment
Number of shares to be purchased under the securities purchase agreement \| shares						8,710,800
Number of shares to be purchased under the securities purchase agreement \| shares			1,212,122
Amount of securities purchase agreement			$ 4.0
Equity and long-term investments at fair value		$ 97.6	$ 88.1				$ 97.6
Minimum [Member] \| One Director
Equity investment
Armata outstanding shares percentage	8.00%
Maximum [Member] \| One Director
Equity investment
Armata outstanding shares percentage	12.50%
Innoviva Strategic Opportunities, LLC \| Common stock and warrants
Equity investment
Amount of securities purchase agreement	$ 45.0				$ 20.0
Innoviva Strategic Opportunities, LLC \| Warrants
Equity investment
Number of warrants to be purchased under the securities purchase agreement \| shares	4,500,000				6,153,847
Exercise price of warrants \| $ / shares	$ 5.00
Innoviva Strategic Opportunities, LLC \| Common stock
Equity investment
Number of shares to be purchased under the securities purchase agreement \| shares	9,000,000				6,153,847